Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average) (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $3.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 148.44% year-over-year to $3.9 million, compared with a TTM value of $3.9 million through Sep 2025, up 148.44%, and an annual FY2024 reading of $17.5 million, up 416.13% over the prior year.
  • Shares Outstanding (Weighted Average) was $3.9 million for Q3 2025 at China Pharma Holdings, up from $3.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $45.6 million in Q1 2021 and bottomed at $1.1 million in Q4 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $8.7 million, with a median of $3.3 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Weighted Average) tumbled 89.61% in 2022, then surged 416.13% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $4.6 million in 2021, then tumbled by 77.21% to $1.1 million in 2022, then soared by 221.82% to $3.4 million in 2023, then soared by 416.13% to $17.5 million in 2024, then plummeted by 77.82% to $3.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CPHI at $3.9 million in Q3 2025, $3.3 million in Q2 2025, and $3.3 million in Q1 2025.